Tag: Matthew Yeowart
Firms act on Hengrui-GSK USD12.5bn drug development deal
Jiangsu Hengrui and GSK reached a USD12.5bn deal, with Cooley, Davis Polk and Han Kun advising
English
Jiangsu Hengrui and GSK reached a USD12.5bn deal, with Cooley, Davis Polk and Han Kun advising
Disputes partners must leave their law firms in order to practise as senior advocates. IBLJ asks leading lawyers whether it is time for change
Follow us on LinkedIn